gene editing

News

Bayer trumpets $1bn CRISPR deal with Mammoth Bio

Bayer has bolstered its cell and gene therapy platform by securing access to a CRISPR-based gene-editing platform developed by US biotech Mammoth Biosciences.

News

Vertex builds in gene editing yet again, with $1.2bn Arbor d...

Vertex Pharma has ramped up its involvement in gene-editing medicines for the third time in a matter of months, agreeing a partnership with CRISPR specialist Arbor Biotechnologies that coul

News

Genetic engineeering concept with 3d rendering robotic hand editing dna helix

Intellia, Regeneron ace first trial with 'in vivo' CRISPR dr...

The first ever clinical data with a CRISPR/Cas9 drug used to edit the genomes of cells within the body has yielded impressive results in patients with ATTR amyloidosis, a life-threatening r

News

Nobel winner Charpentier's CRISPR Therapeutics gets $900m in...

CRISPR Therapeutics is to receive a hefty $900m payment from Vertex after the companies amended a collaboration to develop, manufacture and market a gene editing therapy for sickle cell dis

News

Vertex eyes controllable genetic drugs with $1.3bn Obsidian ...

Vertex Pharma has ramped up its involvement in gene-editing medicines for the second time in a week, paying Obsidian Therapeutics $75 million upfront to access its technology platform.

Views & Analysis

Casting aside CRISPR scissors and making a point with base e...

Dr Jennifer Harbottle, senior scientist in the R&D Base Editing team of PerkinElmer’s Horizon Discovery business, looks at progress made in the realms of biotechnology and next-generati

Bayer trumpets $1bn CRISPR deal with Mammoth Bio

Vertex builds in gene editing yet again, with $1.2bn Arbor d...

Intellia, Regeneron ace first trial with 'in vivo' CRISPR dr...

Nobel winner Charpentier's CRISPR Therapeutics gets $900m in...

Vertex eyes controllable genetic drugs with $1.3bn Obsidian ...

Casting aside CRISPR scissors and making a point with base e...

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

gene editing

Editor's Picks